|
Many significant and currently untreatable human diseases arise from the loss or malfunction of specific cell types in the body. This is especially true of diseases associated with aging, such as Parkinson's disease, diabetes, heart disease, immunodeficiency states, arthritis, and cancer. Cellular GenetiX believes that replacing the malfunctioning cells with fully functional ones may be a useful therapeutic strategy for many of these diseases. This emerging industry is often called regenerative medicine or cell therapy, and it refers to the production of cells as a vehicle to treat disease.
Cellular GenetiX has aligned itself with organizations involved in regenerative medicine. One such organization is TheraVitae.
About TheraVitae
TheraVitae is an emerging healthcare company focused on using the patient's own cells to treat a variety of disorders, especially cardiovascular diseases. TheraVitae is an international company, based in Bangkok, Thailand and Kiryat Weizmann, Israel, benefiting from collaborations with eminent physicians and scientists who are affiliated with well-known medical and academic institutions.
 TheraVitae has developed a stem cell technology called VesCell™. VesCell™ uses a patient's own adult stem cells, which have been harvested from approx. ½ pint of the patient’s own blood, to treat Heart Disease and is a viable alternative for patients who either cannot undergo or choose not to undergo standard treatments such as Coronary Artery Bypass Grafting (CABG).
Heart Conditions Treatable with VesCell™
- Ischemic Heart Disease (Coronary Artery Disease)
- Cardiomyopathy
- Heart Failure
- Severe Angina Pectoris
Cellular GenetiX is dedicated to developing the foundation for this prosperous and exciting industry and allowing patients the ability to take advantage of these novel therapies. Cellular GenetiX is currently providing services of aligning patients, physicians, and hospital systems with laboratories involved with these therapies.
For more information on the clinical application of Regenerative Medicine please call (215) 665-1193 or email info@CellularGenetiX.com.
|
–